Press Coverage

FDA Worried Drug Was Risky; Now Reports of Death Spark Concern

CNN investigative report explores possible medication safety issues with Nuplazid, a drug approved to treat Parkinson's Disease psychosis, including findings from an ISMP QuarterWatch report analyzing adverse event data. For the full text of the article, visit CNN online.

More News

Healthcare Leaders Urged to Avoid Severity Bias, Establish Just Culture In the wake of recent criminal charges being filed against a registered nurse in Tennessee who was involved in a fatal medication error, the Institute for Safe Medication Practices (ISMP) is emphasizing that the focus should be